Skip to main content

Day: March 5, 2026

CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

‒ Q4 2025 Net Revenue of $128.6 million ‒ ‒ Pro Forma Full Year 2025 Net Revenue of $401.3 million ‒   ‒ Q4 2025 Net Income of $14.0 million; Adjusted EBITDA of $77.2 million ‒ ‒ Conference Call Scheduled for Today at 8:30 a.m. Eastern Time ‒ PARSIPPANY, N.J., March 05, 2026 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced financial results for the fourth quarter and full-year ended December 31, 2025 and provided an update on its business. Recent Corporate Highlights:CorMedix announces $128.6 million of net revenue for the fourth quarter of 2025, largely driven by continued utilization of DefenCath by its outpatient dialysis customers. DefenCath sales contributed $91.2 million...

Continue reading

VenHub Secures Agreements for Six New Autonomous Smart Store Locations Across Las Vegas

LAS VEGAS, March 05, 2026 (GLOBE NEWSWIRE) — VenHub Global, Inc. (NASDAQ: VHUB) (“VenHub” or the “Company”), a leader in fully autonomous Smart Store technology, announced it has agreements with multiple independent operators for the deployment of six new VenHub Smart Store locations across the Las Vegas metropolitan area. The Smart Store expansion further strengthens the Company’s presence in the city where its corporate headquarters and production operations are based. VenHub plans to install the six new Smart Stores throughout the year as part of its continued expansion in the Las Vegas market. Each Smart Store will provide secure, contactless access to everyday essentials and convenience items, serving both local residents and the millions of visitors who travel through Las Vegas each year. VenHub Smart Stores operate 24 hours...

Continue reading

FTC Solar Announces Fourth Quarter 2025 Financial Results

Fourth Quarter Highlights and Recent DevelopmentsFourth quarter revenue of $32.9 million, up 26% q/q, 148.9% y/y, in line with target guidance Gross margin improvement of approximately 1,500 basis points q/q and 4,900 points y/y Awarded 1GW supply agreement with leading developer for 1P and 2P trackers in U.S. Secured 840MW supply agreement with Lubanzi for 1P and 2P trackers in South AfricaAUSTIN, Texas, March 05, 2026 (GLOBE NEWSWIRE) — FTC Solar, Inc. (Nasdaq: FTCI), a leading provider of solar tracker systems, today announced financial results for the fourth quarter that ended December 31, 2025. “I’m pleased to share that our fourth quarter results came in at the high-end of our target ranges and we continued to position the company for long-term success,” said Yann Brandt, President and Chief Executive Officer of FTC Solar....

Continue reading

Stack Capital Group Inc. Reports 2025 Financial Results

TORONTO, March 05, 2026 (GLOBE NEWSWIRE) — Stack Capital Group Inc., (“Stack Capital” or the “Company”) (TSX:STCK; TSX:STCK.WT.A; TSX:STCK.WT.B) today announced its financial results for the year ended December 31, 2025. Stack Capital reports all amounts in Canadian Dollars unless otherwise stated. FINANCIAL SUMMARYBook Value per Share (BVpS): $15.35, compared to $12.29 as at December 31, 2024 (+24.9% increase) Total Book Value: $202 millionThe increase in Book Value during the year reflects strong performance across core portfolio holdings and disciplined capital deployment across late-stage private market opportunities. PORTFOLIO COMPANY HIGHLIGHTS SpaceXCompleted a tender offer transaction valuing the company at US$800 billion, reflecting continued investor demand and confidence in its long-term growth trajectory Subsequent...

Continue reading

Virtuix Reports Third Quarter and Nine-Month Fiscal 2026 Financial Results

Virtuix: Pioneering Movement in AI-Generated WorldsNet Sales up 41% to $3.0 Million in Nine Months Ended December 31, 2025 Gross Margin Increased by 46% and Operating Expenses Decreased by 45% Strategic Collaboration with Meta and Global Expansion Accelerate Omni One Adoption and Scale AI-Enabled Defense Training and Enterprise Applications Advance Multi-Use Growth Strategy Virtuix Rang the Nasdaq Closing Bell on March 4, 2026 Management to Host Conference Call Today at 8:30 a.m. Eastern Time AUSTIN, Texas, March 05, 2026 (GLOBE NEWSWIRE) — Virtuix Holdings Inc. (NASDAQ: VTIX) (the “Company”), a leading developer of full-body virtual reality systems, today reported financial and operational results for the three and nine months ended December 31, 2025. Figures presented herein are approximate and have been minimally...

Continue reading

Gilat to Highlight Next‑Generation Satellite Connectivity Technologies at Satellite 2026 – “Expanding 5G to Space”

Gilat accelerates the future of 5G NTN multi‑orbit, multi‑service connectivity for global mobility and broadband markets PETAH TIKVA, Israel, March 05, 2026 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today that it will showcase a comprehensive suite of advanced next‑generation satellite communications solutions at Satellite 2026, taking place March 23-26 in Washington, D.C. At the event, Gilat will present its leadership in enabling advanced connectivity across GEO, MEO, and LEO constellations, supporting a diverse set of applications across mobility, enterprise, aviation, and broadband markets.SkyEdge IV, the next‑generation multi‑orbit satellite networking platform with evolution path to 5G NTN, demonstrating...

Continue reading

Kraig Biocraft Laboratories Targets New Industrial and Defense Biomaterials as “Project Atlas” Hits Major Milestone

ANN ARBOR, Mich., March 05, 2026 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced a major milestone in “Project Atlas”, the Company’s next-generation bioengineering initiative aimed at creating entirely new classes of materials for industrial and defense applications. Kraig Labs first disclosed the existence of Project Atlas on January 19th, 2026, when it was already at an advanced stage of development. The Company described an ambitious effort to merge numerous complex genetic elements into a single integrated architecture. Project Atlas seeks to create new super materials with enhanced strength, toughness, and other properties. Today, Kraig Labs confirms...

Continue reading

Nephros Schedules Fourth Quarter 2025 Financial Results Conference Call

SOUTH ORANGE, N.J., March 05, 2026 (GLOBE NEWSWIRE) — Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its fourth-quarter financial results on Thursday, March 12, 2026 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International access: 1 (412) 317-5285 Upon joining, please ask to be joined into the Nephros conference call. An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page. Alternatively, a replay of the call may be accessed until March 19th, 2026, at 1 (855) 669-9658 or 1 (412) 317-0088 for international callers and entering replay access code:...

Continue reading

Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates

Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth quarter-over-quarter 2025 year-end cash and cash equivalents of $226.7 million after raising over $200 million from financing transactions in 2H 2025 Announced initiation of DECLARATION Phase 3 pivotal clinical trial of vaccine-alternative antibody VYD2311 to prevent COVID, with top-line data expected mid-2026; Fast Track designation for VYD2311 granted by FDA in December 2025 DECLARATION trial on track with full enrollment achieved DECLARATION trial Independent Data Monitoring Committee (IDMC) prespecified review of unblinded VYD2311 safety data resulted in IDMC recommendation to allow enrollment of pregnant and breastfeeding women in the DECLARATION trial DECLARATION trial blinded, pooled early COVID event...

Continue reading

USA Rare Earth to Acquire Texas Mineral Resources Corporation

Transaction Establishes USAR as Exclusive Operator of the Round Top Heavy Rare Earth and Critical Minerals Project Round Top is North America’s Richest Known Deposit of Heavy Rare Earths and Critical Minerals STILLWATER, Okla., March 05, 2026 (GLOBE NEWSWIRE) — USA Rare Earth, Inc. (Nasdaq: USAR) (“USAR”) and Texas Mineral Resources Corp. (OTCQB: TMRC) (“TMRC”) today announced a definitive agreement for USAR to acquire all of the outstanding shares of TMRC for 3,823,328 shares of USAR common stock. The acquisition secures outstanding minority interests, establishing USAR as the sole operator and 100% economic beneficiary of the Round Top Project. This strategic transaction streamlines USAR’s operations as it builds a global champion in critical minerals and technology. USAR is developing the leading globally integrated mine to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.